Use of guanabenz and its derivatives for making drugs for treating cystic fibrosis and diseases related to a protein addressing deficiency in the cells
US8252958B2 · kind B2 · utility
0Cited by
3References
8Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 28, 2006 |
| Grant date | Aug 28, 2012 |
| Priority date | — |
| Expiry date | Jun 19, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention concerns the use of guanabenz and its derivatives for making drugs for treating cystic fibrosis and diseases related to a protein addressing deficiency in the cells, said derivatives corresponding to formula (I), wherein: R═H or C1 and the phenyl group comprises two substituents, or a pharmaceutically acceptable salt of said derivatives.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.